// App-Quantinova.ai

3003 : Secondary Erythrocytosis Is Phenotypically Distinct from Polycythemia Vera but Associated with Comparable Rates of Thrombosis at Diagnosis

Researchers

Presenter

  • Eliane Nguyen

Principal Investigators

  • Natasha Szuber

  • Michael Harnois

  • Lambert Busque

  • Luigina Mollica

  • Sarit E Assouline

  • Ines Chamakhi

  • Harold J. Olney

  • Shireen Sirhan

Medical Centers

  • Université de Montréal, Saint-Laurent, QC, Canada

  • Department of Hematology, Hopital Maisonneuve Rosemont, Montreal, Canada

  • University of Montreal, Montreal, QC, Canada

  • Groupe Québécois de Recherche en LMC-NMP/Chronic Myeloid Leukemia and Myeloproliferative Neoplasms Quebec Research Group (GQR LMC-NMP), Montreal, QC, Canada

  • Hopital Maisonneuve-Rosemont, Montreal, QC, Canada

  • Department of Hematology, Hopital Maisonneuve Rosemont, Montreal, Canada

  • Segal Cancer Center, Lady Davis Institute, Jewish General Hospital, Montreal, QC, Canada

  • Division of Hematology,Sir Mortimer B. Davis-Jewish General Hospital, Department of Oncology, McGill University,Montreal, QC,Canada

  • Department of Hematology, Hôpital Sacré-Coeur de Montréal, Montreal, QC, CAN

  • Department of Pathology, Centre Hospitalier De Luniversite De Montreal, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myeloid neoplasms

  • Chronic Myelogenous Leukemia

  • Polycythemia vera

  • Venous thrombosis

Biomarkers

  • Proteasome Subunit Beta 8

Drug/Treatment

  • Erythropoietin

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved